HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by CONNELL, P. P. Articles by MUNDT, A. J. Search for Related Content PubMed PubMed Citation Articles by CONNELL, P. P. Articles by MUNDT, A. J.

Race and Clinical Outcome in Endometrial Carcinoma

From the Departments of Radiation and Cellular Oncology and Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago Hospitals, Chicago, Illinois.

Address reprint requests to: Arno J. Mundt, MD, Department of Radiation and Cellular Oncology, University of Chicago Hospitals, MC 9006, 5758 South Maryland Avenue, Chicago, IL 60637, E-mail: mundt{at}rover.uchicago.edu

Objective: To compare the outcomes of black and white women who have surgically staged endometrial carcinoma.

Methods: We retrospectively compared the clinicopathologic factors, socioeconomic status, treatments, and outcomes of 70 black and 302 white women who were treated for surgically staged endometrial carcinoma at our institution.

Results: Black women had higher-grade tumors, less favorable histologic findings, more comorbid illnesses, and lower socioeconomic indices. A nonsignificant trend was also seen toward more advanced-stage disease. The extent of surgical staging and types of adjuvant therapies were similar. On univariate analysis, black women had worse 5-year disease-free survival than white women (52.8% versus 75.2%; P = .001). Other significant factors included stage, grade, lymph node status, extension to the uterine serosa, cervical involvement, histology, adnexal involvement, lymphovascular invasion, myometrial invasion, positive peritoneal cytology, level of education, and household income. After controlling for pathologic and socioeconomic differences in multivariate analysis, race remained a significant prognostic factor (P = .008; hazard rate 2.0; 95% confidence interval 1.2, 3.5).

Conclusion: In a large cohort of surgically staged and uniformly treated patients with endometrial carcinoma, black race was associated with significantly worse outcomes, even after controlling for clinicopathologic and socioeconomic factors.

This article has been cited by other articles:

				M. M. Zhang, M. K. Cheung, K. Osann, M. M. Lee, S. S. Lin Gomez, A. S. Whittemore, A. Husain, N. N. Teng, and J. K. Chan Improved Survival of Asians With Corpus Cancer Compared With Whites: An Analysis of Underlying Factors Obstet. Gynecol., February 1, 2006; 107(2): 329 - 335. [Abstract] [Full Text] [PDF]

				T. C. Randall and K. Armstrong Differences in Treatment and Outcome Between African-American and White Women With Endometrial Cancer J. Clin. Oncol., November 15, 2003; 21(22): 4200 - 4206. [Abstract] [Full Text] [PDF]